Brief: IX Biopharma's Through Unit Enters Deal With Organic Genetics Group
27/07/2021 02:36
July 27 (Reuters) - IX Biopharma Ltd IXBI.SI :
* CO THROUGH UNIT ENTERED DEAL WITH ORGANIC GENETICS GROUP
TO
SUPPLY CO'S NOVEL SUBLINGUAL MEDICINAL CANNABIS WAFERS IN NEW
ZEALAND
Source text for Eikon: ID:nSN1sSb5m
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture